Elsevier launches PharmaPendium drug research platform
Elsevier, a global leader in information and data analytics, has launched the new PharmaPendium, sharpening the translational view of a platform that combines extensive preclinical and clinical data, including complete Food and Drug Administration (FDA) and European Medicines Agency (EMA) approval packages, with predictive tools to accelerate drug development.
Olivier Barberan Eli Lilly Pierre Fabre Drug Administration European Medicines Agency Boehringer Ingelheim
Source: sciencebusiness.net